• Je něco špatně v tomto záznamu ?

Long-term adaptation to high doses of morphine causes desensitization of mu-OR- and delta-OR-stimulated G-protein response in forebrain cortex but does not decrease the amount of G-protein alpha subunits

L. Bourova, M. Vosahlikova, D. Kagan, K. Dlouha, J. Novotny, P. Svoboda,

. 2010 ; 16 (8) : BR260-70.

Jazyk angličtina Země Polsko

Typ dokumentu časopisecké články, práce podpořená grantem

Perzistentní odkaz   https://www.medvik.cz/link/bmc12026204

BACKGROUND: The functional activity of trimeric guanine-nucleotide-binding proteins (G-proteins) represents an essential step in linking and regulation of the opioid receptor (mu-, delta- and kappa-OR)-initiated signaling pathways. Theoretical basis and/or molecular mechanism(s) of opioid tolerance and addiction proceeding in the central nervous system were not studied in the forebrain cortex of mammals with respect to quantitative analysis of opioid-stimulated trimeric G-protein activity. MATERIAL/METHODS: G-protein activity was measured in PercollR-purified plasma membranes (PM) isolated from the frontal brain cortex of control and morphine-treated rats by both high-affinity [32P]GTPase and [35S]GTPgammaS binding assays. Exposition to morphine was performed by intra-muscular application of this drug. Control animals were injected with sterile PBS. RESULTS: Both mu-OR (DAMGO)- and delta-OR (DADLE)-responses were clearly desensitized in PM isolated from morphine-treated rats; kappa-OR (U-69593)- and baclofen (GABAB-R)-stimulated [35S]GTPgammaS binding was unchanged, indicating the specificity of the morphine effect. Under such conditions, the amount of G-protein alpha subunits was unchanged. The order of efficacy DADLE>DAMGO>U-69593 was the same in control and morphine-treated PM. Behavioral tests indicated that morphine-treated animals were fully drug-dependent and developed tolerance to subsequent drug addition. CONCLUSIONS: Prolonged exposure of rats to high doses of morphine results in decrease of the over-all output of OR-stimulated G-protein activity in the forebrain cortex but does not decrease the amount of these regulatory proteins. These data support the view that the mechanism of the long-term adaptation to high doses of morphine is primarily based on desensitization of OR-response preferentially oriented to mu-OR and delta-OR.

000      
00000naa a2200000 a 4500
001      
bmc12026204
003      
CZ-PrNML
005      
20121210093008.0
007      
ta
008      
120817s2010 pl f 000 0#eng||
009      
AR
035    __
$a (PubMed)20671607
040    __
$a ABA008 $b cze $d ABA008 $e AACR2
041    0_
$a eng
044    __
$a pl
100    1_
$a Bourova, Lenka $u Laboratory of Membrane Receptors, Institute of Physiology, Academy of Sciences of the Czech Republic, Prague, Czech Republic. bourova@biomed.cas.cz
245    10
$a Long-term adaptation to high doses of morphine causes desensitization of mu-OR- and delta-OR-stimulated G-protein response in forebrain cortex but does not decrease the amount of G-protein alpha subunits / $c L. Bourova, M. Vosahlikova, D. Kagan, K. Dlouha, J. Novotny, P. Svoboda,
520    9_
$a BACKGROUND: The functional activity of trimeric guanine-nucleotide-binding proteins (G-proteins) represents an essential step in linking and regulation of the opioid receptor (mu-, delta- and kappa-OR)-initiated signaling pathways. Theoretical basis and/or molecular mechanism(s) of opioid tolerance and addiction proceeding in the central nervous system were not studied in the forebrain cortex of mammals with respect to quantitative analysis of opioid-stimulated trimeric G-protein activity. MATERIAL/METHODS: G-protein activity was measured in PercollR-purified plasma membranes (PM) isolated from the frontal brain cortex of control and morphine-treated rats by both high-affinity [32P]GTPase and [35S]GTPgammaS binding assays. Exposition to morphine was performed by intra-muscular application of this drug. Control animals were injected with sterile PBS. RESULTS: Both mu-OR (DAMGO)- and delta-OR (DADLE)-responses were clearly desensitized in PM isolated from morphine-treated rats; kappa-OR (U-69593)- and baclofen (GABAB-R)-stimulated [35S]GTPgammaS binding was unchanged, indicating the specificity of the morphine effect. Under such conditions, the amount of G-protein alpha subunits was unchanged. The order of efficacy DADLE>DAMGO>U-69593 was the same in control and morphine-treated PM. Behavioral tests indicated that morphine-treated animals were fully drug-dependent and developed tolerance to subsequent drug addition. CONCLUSIONS: Prolonged exposure of rats to high doses of morphine results in decrease of the over-all output of OR-stimulated G-protein activity in the forebrain cortex but does not decrease the amount of these regulatory proteins. These data support the view that the mechanism of the long-term adaptation to high doses of morphine is primarily based on desensitization of OR-response preferentially oriented to mu-OR and delta-OR.
650    _2
$a fyziologická adaptace $x účinky léků $7 D000222
650    _2
$a zvířata $7 D000818
650    _2
$a baklofen $x farmakologie $7 D001418
650    _2
$a chování zvířat $x účinky léků $7 D001522
650    _2
$a buněčná membrána $x účinky léků $x enzymologie $7 D002462
650    _2
$a mozková kůra $x účinky léků $x metabolismus $7 D002540
650    _2
$a vztah mezi dávkou a účinkem léčiva $7 D004305
650    _2
$a tolerance léku $7 D004361
650    _2
$a enkefalin, Ala(2)-MePhe(4)-Gly(5)- $x farmakologie $7 D020875
650    _2
$a proteiny vázající GTP - alfa-podjednotky $x metabolismus $7 D044385
650    _2
$a guanosin 5'-O-(3-thiotrifosfát) $x metabolismus $7 D016244
650    _2
$a guanosindifosfát $x metabolismus $7 D006153
650    _2
$a mužské pohlaví $7 D008297
650    _2
$a morfin $x aplikace a dávkování $x farmakologie $7 D009020
650    _2
$a krysa rodu Rattus $7 D051381
650    _2
$a potkani Wistar $7 D017208
650    _2
$a receptory opiátové delta $x agonisté $x metabolismus $7 D017465
650    _2
$a receptory opiátové mu $x agonisté $x metabolismus $7 D017450
650    _2
$a abstinenční syndrom $x patofyziologie $7 D013375
650    _2
$a časové faktory $7 D013997
655    _2
$a časopisecké články $7 D016428
655    _2
$a práce podpořená grantem $7 D013485
700    1_
$a Vosahlikova, Miroslava
700    1_
$a Kagan, Dmytro
700    1_
$a Dlouha, Katerina
700    1_
$a Novotny, Jiri
700    1_
$a Svoboda, Petr
773    0_
$w MED00003251 $t Medical science monitor : international medical journal of experimental and clinical research $x 1643-3750 $g Roč. 16, č. 8 (2010), s. BR260-70
856    41
$u https://pubmed.ncbi.nlm.nih.gov/20671607 $y Pubmed
910    __
$a ABA008 $b sig $c sign $y m
990    __
$a 20120817 $b ABA008
991    __
$a 20121210093044 $b ABA008
999    __
$a ok $b bmc $g 948246 $s 783550
BAS    __
$a 3
BAS    __
$a PreBMC
BMC    __
$a 2010 $b 16 $c 8 $d BR260-70 $i 1643-3750 $m Medical Science Monitor $n Med Sci Monit $x MED00003251
LZP    __
$a Pubmed-20120817/10/04

Najít záznam

Citační ukazatele

Nahrávání dat ...

Možnosti archivace

Nahrávání dat ...